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Interleukin-6 and its soluble receptor
during acute meningococcal infections: Effect of
plasma or whole blood exchange
Johan T. M. Frieling, MD; Marcel van Deuren, MD; John Wijdenes, PhD; Roelof van Dalen, MD; 
Anton K. M. Bartelink, MD; Cees J. van der Linden, MD, PhD; Robert W. Sauerwein, MD, PhD
Objectives: To determine the pattern of the soluble interleukin 
(IL)-6 receptor during acute meningococcal infections and recov­
ery phase, and to measure the effect of plasma or whole blood 
exchange on the plasma concentrations of these mediators.
Design: Prospective, descriptive patient study.
Setting: University ^jspital intensive care unit.
Patients: Patients with bacteriologically proven meningococ­
cal infections were entered in the study. Three group were formed: 
a) patients with meningitis without shock (group A); b) patients 
with meningitis and shock (group B); and c) patients with shock 
only (group C).
Interventions: Part (n = 9) of the patients with shock underwent 
plasma or whole blood exchange.
Measurements and Main Results: Serum concentrations of 
interleukin-6 and soluble IL-6 receptors were determined sequen­
tially during the acute and recovery phases. Peak concentrations 
of IL-6 were highest in group C, followed by group B and group A.
Soluble IL-6 receptor concentrations showed an opposite pattern 
and were all below normal. Soluble IL-6 receptor concentrations 
were negatively correlated with the IL-6 concentrations. During 
recovery, IL-6 rapidly decreased and soluble IL-6 receptors in­
creased to supranormal concentrations, after which concentra­
tions returned to normal. Plasma or whole blood exchange did not 
significantly influence IL-6 concentrations but did increase the 
soluble IL-6 receptor concentration directly after an exchange 
session followed by a rapid decrease.
Conclusions: Soluble IL-6 receptor concentrations are low in 
acute meningococcal infections. Plasma or whole blood exchange 
temporarily increases these concentrations. It needs to be deter­
mined whether the effect of this therapy is beneficial to the patient. 
(Crit Care Med 1996; 24:1801-1805)
Key Words: interleukin-6; Neisseria meningitidis; plasma ex­
change; interleukln-6 receptor; bacterial infection; mediators; 
cytokines; infection; critical illness
mong the acute bacterial in- of IL-6 in the pathogenesis of septic the presence of soluble IL-6 receptor 
fections, meningococcal shock has not been elucidated. An im- enhances the biological activity of IL- 
infections are one of the portant function of IL-6 is presumably 6 (10, 11). Studies on the patterns and 
most life-threatening dis- to act as a mediator between damaged effects of this soluble receptor are nec­
eases. The Gram-negative bacterium, tissues and the liver, where it is a essary to understand the biological sig- 
Neisseria meningitidis, can induce a potent inducer of acute-phase proteins, nificance of this phenomenon.
clinical disease that varies from men- Soluble receptors for various We studied the pattern of IL-6 and
ingitis to a rapidly deteriorating sepsis cytokines have been shown to modu- its soluble receptor in the acute and 
syndrome with severe shock and a mor- late the biological effects of their ligand recovery phases of meningococcal to­
tality rate of 30% to 70% (1). High (5). TNF activity, for example, is de- fections. A number of the study pa- 
concentrations of the proinflammatory creased in the presence of soluble TNF tients underwent plasma or 
cytokines, interleukin (IL)-6 and tu- receptor by competitive inhibition (6); blood exchange, which 
mor necrosis factor (TNF), are found in contrast, low concentrations
im-
proves clinical signs of sepsis and sur- 
can increase vival (12-15). Because the mechanismin these patients, and these cytokine soluble TNF 
concentrations correlate with disease the effects of TNF by prolonging its behind the beneficial effect of this pro­
severity and outcome (2-4). The role half-life (7). I■9
tMMt iwmiwi Soluble IL-6 receptor,
cedure has yet to be elucidated, 
effects of plasma or whole blood ex-
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Patients
receptor (gpl30) and generate a signal proven mening 
into the cell. Through this mechanism admitted to care unit
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were included in. the study. Cultures 
for Neisseria meningitidis had to be 
positive from at least one of the fol­
lowing sites: blood, cerebrospinal fluid 
(CSF), and/or skin lesion. According 
to Halstensen et al. (16), three groups 
were discriminated. Group A (n = 13) 
showed a meningococcal infection of 
the central nervous system without 
shock; group B (n = 5) showed a men­
ingococcal infection of the central ner­
vous system plus shock; and group C 
(n = 5) showed no sign of inflamma- 
tion of the central nervous system but 
only shock. Infection of the central ner­
vous system was defined as a leuko­
cyte count of >100 cells x 10(i/L in
CSF. During the first hours after ad­
mission, shock was defined prospec- 
tively as a systolic blood pressure of 
<100 mm Hg in patients >14 yrs of 
age, <85 mm Hg in children <14 yrs of 
age, and <75 mm Hg in patients <4 
yrs of age. Demographics of the pa­
tients are given in Table 1. Four pa­
tients in group B and all patients in 
group C underwent plasma or whole 
blood exchange (12). In patients with 
a body weight of <25 kg, 50 to 60 mL 
of whole blood/kg were exchanged each 
session. In patients with body weight 
of >25 kg 30 to 40 mL plasma/kg were 
exchanged with fresh frozen plasma 
each session. The exchange was started
Table 1. Patient demographics
Group A 
(n = 13)
Group B 
(n = 5)
Group C 
(n = 5)
Male/female 5/8 3/2 4/1
Age" (yr) 15 (2-64) 15 (0-17) 8 (2-18)
Prehospital disease
period" (hr) 23.5 (12.5-84) 14 (5-30) 14 (7-16.5)'’
Mortality (n) 1 1
PE/BE (n/n) 0/0 3/1 3/2
Leukocytes in CSF“
(10fi/L) 21674(3900-70000) 417 (107-6000)'' 14(1-45)^
Group A, meningococcal infection of the central nervous system without shock; Group B, 
meningococcal infection of the central nervous system with shock; Group C, meningococcal 
infection of the central nervous system with shock but no signs of inflammation of the central 
nervous system; PE, plasma exchange; BE, blood exchange; CSF, cerebrospinal fluid.
“Medians, with ranges in parentheses; '’significantly different from group A; "significantly 
different from group B.
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Figure 1. Peak concentrations for interleukin-6 (IL-6) and soluble interleukin-6 receptor 
(sIL-6R) of each individual patient; medians are indicated (A vs. B, and A vs. C: p < .001). 
Group A, meningococcal infection of the central nervous system without shock; group B, 
meningococcal infection of the central nervous system wi th shock; group C, meningococcal 
infection of the central nervous system with shock but no signs of inflammation of the 
central nervous system.
as soon as possible after admission 
and was repeated after 12 hrs. When 
the patients’ condition remained criti­
cal, the exchange was repeated 24 and 
48 hrs later.
After admission, serum samples 
were collected serially during the first 
day and each following day. Blood was 
allowed to clot before centrifugation, 
and serum was stored at -20°C until 
tested. Samples were also taken di- 
rectly before and after the exchange of 
plasma or blood.
Soluble IL-6 receptor and IL-6 con­
centrations were determined by en­
zyme-linked immunosorbent assays 
(ELISAs) (17). These ELISAs are not 
influenced by the presence of soluble 
IL-6 receptor in the IL-6 ELISA or IL- 
6 in the soluble IL-6 receptor ELISA 
(17). Detection limits for the IL-6 
ELISA and the soluble IL-6 receptor 
ELISA were 20 pg/mL, and 0.4 ng/mL, 
respectively. Concentrations in normal 
volunteers for IL-6 and soluble IL-6 
receptor are <20 pg/mL and 76.6 ± 
19.3 (s d ) ng/mL, respectively (17).
Statistical Analysis. Differences 
between groups were calculated with 
the Wilcoxon rank-sum test. Differ­
ences were considered significant with 
a two-tailed p  value of <.05. Relation­
ships between IL-6 and soluble IL-6 
receptor were calculated using the 
Spearman correlation coefficient.
RESULTS
Figure 1 shows the peak concentra­
tions of IL-6 and concomitant soluble 
IL-6 receptor concentration for each 
individual patient subdivided into the 
three groups. Median IL-6 peak con­
centrations were 703 pg/mL, 6942 pg/ 
mL, and 120,800 pg/mL in group A 
(meningococcal infection of the cen­
tral nervous system without shock), 
group B (meningococcal infection of 
the central nervous system, with 
shock), and group C (meningococcal 
infection of the central nervous sys­
tem with shock but no signs of inflam­
mation of the central nervous system), 
respectively. For soluble IL-6 recep­
tor, the concentrations were 56 ng/mL 
in group A, 12 ng/mL in group B, and 
7 ng/mL in group C. The peak values 
for IL-6 differed significantly between 
groups A and B (p = .0009), and groups 
A and C (p = .0002), but not between 
groups B and C (p = .31). For soluble
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IL-6 receptor concentrations, the 
differences between groups A and B, 
and groups A and C were significant 
(p = .0009 and .0005, respectively). 
There was no statistically significant 
difference between groups B and C (p 
= .42).
All patients in each group had de­
tectable IL-6 concentrations on entry 
in the study which gradually decreased 
during recovery. In contrast, soluble 
IL-6 receptor concentrations were low 
on admission and increased to supra- 
normal concentrations before leveling 
off to normal concentrations. IL-6 con­
centrations returned to normal after 
~48 hrs. Soluble IL-6 receptor concen­
trations, however, returned to normal 
ranges only after 120 to 160 hrs.
There was a strong negative corre­
lation between IL-6 and soluble IL-6 
receptor concentrations. For the peak 
concentration of IL-6 and its relation­
ship with soluble IL-6 receptor con­
centration, the Spearman correlation 
coefficient was -0.82.
Figure 2 shows the patterns of IL-6 
and Figure 3 illustrates the patterns 
of soluble IL-6 receptor values over 
time in all patients of each group. In 
patients who underwent plasma or 
whole blood exchange, the sessions are 
indicated by thick lines. Soluble IL-6 
receptor concentration is temporarily 
increased after a plasma or whole blood 
exchange session. At the onset of the 
disease, when IL-6 concentrations are 
high, this increase of soluble IL-6 re­
ceptor concentration is quickly nulli-
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Figure 2. Patterns of interleukin-6 (IL-6) 
reacti vity of all patients in groups A, B, and 
C. Solid lines indicate plasma or whole blood 
exchange sessions. Group A, meningococcal 
infection of the central nervous system with-
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Figure 3. Patterns of 
receptor (slL-6R) of all patients in groupsA, 
B, and C. Solid linen indicate plasma or 
out shock; group B, meningococcal infection whole blood exchange sossiona. Group A,
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effect of plasma exchange is followed group C, meningococcal infection of the cen- vous sys tem without shock; Group B, men-
by an increase in the soluble IL-6 re­
ceptor concentration. This phenom­
enon can be visualized by the calcula­
tion of the change of soluble IL-6 
receptor concentration per hour after 
an exchange session by the following
tral nervous system with shock but no signs ingococcal infection of the central nervous 
of inflammation of the central nervous system with shock; Group C, meni
mi. infection of the central nervous system with 
shock hut no signs of inflammation of the 
central nervous system.
(soluble IL-6 receptor)B in re to
(soluble. IL-6 receptor)AfhrB between at point 
A and B, where (s
IL-6
;at
is
IL-6 reccptor )A 
of soluble IL-6 
receptor in ng/mL measured just after 
an exchange session, and (soluble IL-6 
receptor)B is the concentration of 
soluble IL-6 receptor in ng/mL meas-
is -0.81 (p < .
concentrations, indicating a cl oho re­
lation of these two parameter«.
Recently, we (18) reported that the 
soluble IL-6 receptor concentration was
m pi
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j-6 concentrations group A
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soluble IL-6 receptor concentration 
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Positive the
showed low concentrations of 
IL-6 receptor,
for soluble IL-6 recep- 
be decreased. The
concentration of IL-6 appears to v
soluble IL-6 receptor concentration in­
creases after the exchange session.
IL-6 receptor 
negative correlation is found
IL-6 and soluble IL-6 receptor IL-6 receptor concentration, which is
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1 0 .0- patients plasma would be ±65 ng/mL To our knowledge, this study is the
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Figure 4. Change of soluble IL-6 receptor
at the end of the session. The differ- first report to strongly point to an
ence with the actual concentration important role for IL-6 in maintaining
could be the result of ongoing clear- soluble IL-6 receptor concentrations
ance of soluble IL-6 receptors in either and in clearance of the soluble IL-6
free or complexed form with IL-6. receptor in patients. Studies on the
Plasma or whole blood exchange did underlying mechanisms, however, still
not significantly influence the IL-6 con- have to be done, 
centration. It needs to be determined 
whether the increase in soluble IL-6 
receptor concentrations is of benefit
for the patient, because an increase of i. Giraud T, Dhainaut J-F, Schremmer B,
REFERENCES
CsIL-6R) concentration per hour (for the for- the biological activity of IL-6 by bind- 
mula, see the Results section) after a plasma ing to soluble IL-6 receptors may be 
or whole blood exchange jsession related to harmful to the patient. However, ben­
eficial effects of plasma or whole blood 
exchange have been reported. High 
concentrations of cytokines may not 
be the one and only determinant for 
in agreement with the negative the outcome of sepsis patients, as sug- 
correlation between concentrations of gested by lack of efficacy of cytokine 
IL-6 and soluble IL-6 receptor (Figs. 2 antagonists in clinical trials (19).
the interleukin-6 (IL-6) concentration. 
Dashed lines indicate the 95% confidence 
interval.
et al: Adult overwhelming meningococ­
cal purpura. A study of 35 cases 
1977-1989. Arch Intern Med 1991; 151: 
310-316
2. Van Deuren M, Van der Ven-Jongekrijg 
J, Bartelink AKM, et al: Correlation 
between proinflammatory cytokines 
and antiinflammatory mediators and 
the severity of disease in meningococ­
cal infections. J  Infect Dis 1995; 172: 
433-439
3. Waage A, Brandtzaeg P, Halstensen A, 
et al: The complex pattern of cytokines 
in serum from patients with meningo­
coccal septic shock. J  Exp Med 1989; 
169:333-338
tions of IL-6 could be explained by a is h ig h .. The rate of decrease is de- 4. Hack CE, De Groot ER, Felt-Bersma
and 3). After an exchange session, the
The supranormal concentrations of soluble IL-6 receptor concentration 
soluble IL-6 receptor that we see in rapidly decreases, which indicates that 
patients with undetectable concentra- the turnover of soluble IL-6 receptor
delay in the regulation of soluble IL-6 pendent on the IL-6 concentration. In 
receptor concentrations. Assuming an early phase of the illness with high 
that under conditions with high IL-6 IL-6 concentrations, soluble IL-6 re­
concentrations, soluble IL-6 receptor ceptors are more quickly cleared from 
or IL-6/soluble IL-6 receptor complexes the exchanged plasma than in a later 
are rapidly cleared from the circula- phase when plasma IL-6 concentra­
tion, a counter regulation starts lead- tions are low. At low IL-6 concen-
RJF, et al: Increased plasma levels of 
interleukin-6 in sepsis. Blood 1989; 
74:1704-1710 
5. Girardin E, Roux-Lombard P, Grau GE, 
et al: Imbalance between tumour ne­
crosis factor-alpha and soluble TNF re­
ceptor concentrations in severe menigo- 
coccaemia. Immunology 1992; 76:20-23
ing to increased production or shed- trations, soluble IL-6 receptor concen- 6. Van Zee KJ, Kohno T, Fischer E, et al:
Tumor necrosis factor soluble receptors 
circulate during experimental and clini­
cal inflammation and can protect against 
excessive tumor necrosis factor-a in 
vitro and in vivo. Proc Natl Acad Sci
U S A  1992; 89:4845-4849
7. Aderka D, Engelmann H, Maor Y, et al: 
Stabilization of the bioactivity of tumor 
necrosis factor by its soluble receptors.
JE xp  Med 1992; 175:323-329
8. Miillberg J, Schooltink H, Stoyan T, et 
al: The soluble interleukin-6 receptor is 
generated by shedding. Eur J  Immunol 
1993; 23:473-480
tively low concentration of soluble IL- (20-22) were performed on different 9. Lust JA, Donovan KA, Kline MP, et al:
Isolation of an mRNA encodi ng a soluble 
form of the human interleukin-6 recep-
ding of soluble IL-6 receptor, trations do not further decrease but
Temporarily increased soluble IL-6 re- increase after an exchange session,
ceptor concentrations may be the re- This finding indicates that IL-6 is an
suit of continuing high IL-6 produc- important factor for the clearance of
tion and reduced clearance of soluble soluble IL-6 receptor. In vitro studies,
IL-6 receptor. however, are not conclusive about the
The concentrations of soluble IL-6 effect of IL-6 on the IL-6 receptor
receptor in the patients undergoing expression or soluble IL-6 receptor
plasma or whole blood exchange are production. Some reports (20, 21)
markedly increased after an exchange indicated a decrease of the expression
session. This finding can be explained of IL-6 receptor, but another report
by the fact that plasma with a rela- (22) showed no effect. These studies
6 receptor is partially replaced with cell types under different experimen-
plasma containing normal concen- tal conditions. Very little is known
trations of soluble IL-6 receptor, about the mode of clearance of the
Plasma soluble IL-6 receptor concen- soluble IL-6 receptor. Minute amounts
tration of one patient, for instance, of soluble IL-6 receptor are found in
was 5 ng/mL before and 30 ng/mL af- the urine, and moderate renal impair-
ter the first plasma exchange session ment does not influence the soluble
tor. Cytokine 1992; 4:96-100 
10. Mackiewcz A, Schooltink H, Heinrich P, 
et al: Complex of soluble human IL-6- 
receptor/IL-6 upregulates expression of 
acute phase proteins. J  Immunol 1992; 
149:2021-2027
with 2400 mL of fresh frozen plasma. IL-6 receptor concentration (17). How- Gaillard J-P, BatailleR, BraillyH, etal:
If the mixture of donor blood with the ever, preliminary results in patients
patient’s blood after each portion is with almost absent renal function do
taken into account, and the plasma indicate a role for the kidneys in main-
soluble IL-6 receptor concentration of taining soluble IL-6 receptor concen-
Increased and highly stable levels of 
functional soluble interleukin-6 recep­
tor in sera of patients with monoclonal 
gammopathy. Eur J  Immunol 1993; 23: 
820-824
the donor blood is estimated to be 80 trations (Frieling et al., unpublished 12. Van Deuren M, Santman FW, Van Dalen
ng/mL, the concentration in the observation). R, et al: Plasma and whole blood
1804 Crit Care Med 1996 Vol. 24, No. 11
exchange in meningococcal sepsis. Clin 
InfDis 1992; 15:424-430
13. Janbon B, Vuillez J, Carpentier F, et al: 
Removal of circulating tumor necrosis 
factor. Its role in septic shock treatment. 
Ann Med Interne 1992; 143(Suppl 1): 
13-16
14. Brandtzseg P, Sirnes K, Folsland B, et 
al: Plasmapheresis of severe meningo­
coccal septicaemia with DIC and fibi'i- 
nolysis. Scand J  Clin Lab Invest 1985; 
45(Suppl 178):53-55
15. Bjorvatn B, Bjertnaes L, Fadnes HO, et
exchange. B M J 1984; 288:439-441 
16. Halstensen A, Pedersen SHJ, Haneberg 
B, et al; Case fatality of meningococcal 
disease in western Norway. Scand J
17.
18.
Infect Dis 1987; 19:35-42
Wijdenes
20. Hoffmann R, Iienninger H-P, Schulze- 
Specking A, et al: Regulation of 
interleukin-6 receptor expression in rat 
Kupffer cells: Modulation by cytokines, 
dexamethasone and prostaglandin E„.
J  Hepatol 1994; 21:543-550
J, et al: Soluble interleukin-6 receptor 21. Bauer J, Bauer TM, Kalb T, et al: Regu-
in biological fluids from human origin.
Cytokine 1994;6:376-381
Frieling JTM, Van Deuren M, Wijdenes
J, et al: Circulating interleukin-6 re-
lation of interleukin 6 receptor expres­
sion in human monocytes and monocyte 
derived macrophages. J  Exp Med 1989; 
170:1537-1549
ceptor in patients with sepsis syndrome. 22. Schoester M, Heinrich PC, Graeve L:
J  Infect Dis 1995; 171:469-472
al: Meningococcal septicaemia treated 19. Suffredini AF: Current prospects for
with combined plasmapheresis and 
leukapheresis or with whole blood
the treatmant of clinical sepsis. Grit 
Care Med 1994; 22:S12~S18
Regulation of interleukin-6 receptor ex­
pression by interleukin-6 in human
A re-examination. FEBS
Lett 1994; 345:131-1.34
SCCM PRACTICE PARAMETERS
A publication containing the complete unabridged documents of Practice Param eters for 
Intravenous A nalgesia and Sedation for Adult Patients in  the Intensive Care U nit 
and Practice Param eters for Sustained Neuromuscular Blockade in the Adult Criti­
cally 111 Patient is available for purchase from the Society of Critical Care Medicine for $40 
plus $5 for shipping and handling charges (SCCM membership discount applies).
Name
Order Form for SCCM Practice Parameters
Mailing Address
« m u n i i'--. T ■■"---‘T —'  TaiBIItT mwMHuiairriiinw^ iiii i^n iiiaiiini mu m»»» iiBninniM*a ui»wiiiww
City State/Province
winxw m « u w I» » * 'mut mtm inniTi
Zip/Postal Code
■«■'TnTm^ rrTiiïi1 irT,“>r(iwn,nffMi * , " l nr • ~
Country
(Area) Daytime Phone (Area) Fax Number
□ Check# ^Im ki
□ Am. Express □  MasterCard □  Visa Credit Card No.
W lH II i n  ^ in ne »if ii tm ii>JMinwwiiiB>i»i«wiWiuia i »ro>uun<rfin iriinn mwTWinuf m
Signature
Expir. Date
irniii»B«n~iTii 'ii J ' 1 ..... 1' I n»i I»»......
Mail to: SCCM, 8101 E. Kaiser Boulevard, Suite 300, Anaheim, CA 92808-2259. Phone: (714) 282-6056. Fax: 
(714) 282-6050.
iit**fTwuiiim iiini iiiì'i fi"i r r  t im» m
Crit Care Med 1996 Vol. 24, No. 11 1805
